Clinical Trial Update: Efficacy of Aerosal® in the Treatment of Inverse Psoriasis and Sebopsoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Aerosal® for inverse psoriasis and sebopsoriasis has been withdrawn; no efficacy data reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inverse Psoriasis
• Sebopsoriasis

Drugs mentioned

• Aerosal®

Snippet

Sponsor: Tecno Sun SRL | Conditions: Inverse Psoriasis, Sebopsoriasis | Phase 2 | Status: WITHDRAWN